RECRUITING

Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to determine whether an indocyanine green (ICG) fluorescence imaging system (cBPI) can be used to provide surgeons with information about bone health or bone blood flow. This will help surgeons better understand the healing potential of bone and relative risk of complication. This is important to help surgeons select the most appropriate treatment for severe traumatic injuries and infections.

Official Title

Prospective Observational Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients: Early Comparison With a Novel Imaging Device

Quick Facts

Study Start:2025-06-10
Study Completion:2027-06-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06793644

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients 18 years of age or older.
  2. * Open extremity fracture, planning for management with external fixation, internal fixation or joint fusion.
  3. * Fracture Related Infection, planning for management with debridement and possible removal of hardware.
  4. * Will have all planned fracture care surgeries performed by a participating surgeon or delegate.
  5. * Provision of informed consent.
  1. * Inability of patient to provide informed consent
  2. * Fracture of the hand.
  3. * Iodine allergy.
  4. * Burns at the fracture site.

Contacts and Locations

Study Contact

Jon Mikael Anderson
CONTACT
603-653-3306
jon.mikael.anderson@hitchcock.org
Ida L Gitajn, MD
CONTACT
603-650-5000
ida.l.gitajn@hitchcock.org

Principal Investigator

Ida L Gitajn, MD
PRINCIPAL_INVESTIGATOR
Dartmouth-Hitchcock Medical Center

Study Locations (Sites)

Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756
United States

Collaborators and Investigators

Sponsor: Dartmouth-Hitchcock Medical Center

  • Ida L Gitajn, MD, PRINCIPAL_INVESTIGATOR, Dartmouth-Hitchcock Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-10
Study Completion Date2027-06-10

Study Record Updates

Study Start Date2025-06-10
Study Completion Date2027-06-10

Terms related to this study

Keywords Provided by Researchers

  • Immunofluorescence
  • Orthopaedic Trauma
  • Infection

Additional Relevant MeSH Terms

  • Fractures, Bone
  • Trauma Injury